Compare CMPR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPR | HAE |
|---|---|---|
| Founded | 1994 | 1971 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Publishing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.8B |
| IPO Year | 2005 | 1996 |
| Metric | CMPR | HAE |
|---|---|---|
| Price | $100.16 | $75.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $86.50 | $84.13 |
| AVG Volume (30 Days) | 260.6K | ★ 871.5K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.81 | 2.05 |
| Revenue | ★ $3,403,079,000.00 | $910,373,000.00 |
| Revenue This Year | $10.43 | N/A |
| Revenue Next Year | $5.46 | $5.23 |
| P/E Ratio | ★ $34.77 | $36.59 |
| Revenue Growth | ★ 3.38 | N/A |
| 52 Week Low | $42.08 | $47.32 |
| 52 Week High | $106.13 | $87.32 |
| Indicator | CMPR | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 60.21 | 60.56 |
| Support Level | $62.76 | $72.04 |
| Resistance Level | $105.93 | $80.90 |
| Average True Range (ATR) | 4.34 | 2.68 |
| MACD | 0.74 | -0.51 |
| Stochastic Oscillator | 75.86 | 54.12 |
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.